Pharmacokinetics and tolerability of zibotentan (ZD4054) in subjects with hepatic or renal impairment: two open-label comparative studies

Overview of attention for article published in BMC Clinical Pharmacology, March 2011

Altmetric Badge

Mentioned by

So far, Altmetric has seen 3 citations on 3 Wikipedia pages.

齐泊腾坦（INN：Zibotentan，开发代号：ZD4054）是阿斯利康正在开发的一种实验性抗癌候选药物. 它是一种内皮素受体拮抗剂.

Zibotentan (INN; development code ZD4054) is an experimental anti-cancer drug candidate in development by AstraZeneca.

This page shows the most recent Wikipedia articles that mention this research output.

Click here to find out how to access more activity.